Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Sonovue and Sonazoid for detection of colorectal liver metastases
ChiCTR2000038055Phase 4Recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Sep 2020
- Modality
- Small Molecules, Acoustic/Optical: Sonoporation, laser photoporation → Physical Methods → Gene Addition/Replacement → Gene Therapies, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of sulfur hexafluoride and sonazoid in colorectal cancer (CRC) (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoints: Location and size of liver lesions by contrast-enhanced ultrasound, Location and size of liver lesions by intraoperative ultrasound and 2 more. Started Sep 2020; status: recruiting.
02
Drugs
sulfur hexafluoridesonazoid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2000038055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038055.